This study identifies pre-therapy expansion of CD4+ effector memory T cells (TEM) in CMV-infected patients with metastatic melanoma as a prognostic marker of αPD-1/αCTLA-4-related hepatitis. The gene discussed is CD4; the disease is metastatic melanoma.